Public Profile

King-Friend Biochemical Pharmaceutical Co. Ltd.

King-Friend Biochemical Pharmaceutical Co. Ltd., commonly referred to as King-Friend, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1995, the company has made significant strides in the development and production of high-quality biochemical products, primarily focusing on APIs (Active Pharmaceutical Ingredients) and intermediates. With a strong operational presence across various regions, King-Friend has built a reputation for its innovative solutions in the pharmaceutical sector. The company’s core offerings include a diverse range of pharmaceutical raw materials, which are distinguished by their purity and compliance with international standards. Recognised for its commitment to quality and sustainability, King-Friend has achieved notable milestones, positioning itself as a trusted partner in the global pharmaceutical supply chain. Its dedication to research and development continues to drive its success in an increasingly competitive market.

DitchCarbon Score

How does King-Friend Biochemical Pharmaceutical Co. Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

King-Friend Biochemical Pharmaceutical Co. Ltd.'s score of 22 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

16%

Let us know if this data was useful to you

King-Friend Biochemical Pharmaceutical Co. Ltd.'s reported carbon emissions

As of the latest available data, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. has not reported any specific carbon emissions figures in kg CO2e. However, the company is committed to addressing climate change through various initiatives. King-Friend has made a near-term commitment to reduce its carbon footprint, although specific reduction targets have not been disclosed. The company has not yet committed to a net-zero target or defined a long-term reduction strategy. Operating in the Pharmaceuticals, Biotechnology, and Life Sciences sector, King-Friend is part of an industry that is increasingly focusing on sustainability and reducing greenhouse gas emissions. Their commitment to climate action reflects a growing recognition of the importance of environmental responsibility within the pharmaceutical sector. While specific emissions data is currently unavailable, King-Friend's commitment to climate initiatives indicates a proactive approach to managing their environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. King-Friend Biochemical Pharmaceutical Co. Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for King-Friend Biochemical Pharmaceutical Co. Ltd. is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

King-Friend Biochemical Pharmaceutical Co. Ltd. is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Livzon Pharmaceutical

CN
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Glenmark Life Sciences

IN
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Lonza

CH
Furniture; other manufactured goods n.e.c. (36)
Updated 8 days ago

Wuxi Apptec

CN
Research and development services (73)
Updated 22 days ago

Midas Pharma GmbH

DE
Health and social work services (85)
Updated 22 days ago

Centrient Pharmaceuticals Netherlands B.V.

NL
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers